440 related articles for article (PubMed ID: 24654626)
1. Neutropenia during HIV infection: adverse consequences and remedies.
Shi X; Sims MD; Hanna MM; Xie M; Gulick PG; Zheng YH; Basson MD; Zhang P
Int Rev Immunol; 2014; 33(6):511-36. PubMed ID: 24654626
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
Mofenson LM; Brady MT; Danner SP; Dominguez KL; Hazra R; Handelsman E; Havens P; Nesheim S; Read JS; Serchuck L; Van Dyke R; ; ; ; ;
MMWR Recomm Rep; 2009 Sep; 58(RR-11):1-166. PubMed ID: 19730409
[TBL] [Abstract][Full Text] [Related]
3. The changing role of HIV-associated oral candidiasis in the era of HAART.
Patuwo C; Young K; Lin M; Pardi V; Murata RM
J Calif Dent Assoc; 2015 Feb; 43(2):87-92. PubMed ID: 25868223
[TBL] [Abstract][Full Text] [Related]
4. Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study.
Levine AM; Karim R; Mack W; Gravink DJ; Anastos K; Young M; Cohen M; Newman M; Augenbraun M; Gange S; Watts DH
Arch Intern Med; 2006 Feb; 166(4):405-10. PubMed ID: 16505259
[TBL] [Abstract][Full Text] [Related]
5. [Neutropenia in HIV infection].
Moreno García M
An Med Interna; 1997 Apr; 14(4):199-208. PubMed ID: 9181819
[TBL] [Abstract][Full Text] [Related]
6. Deficient Phagocytosis Among HIV-1 Infected Adults Over Time Even in HAART Setting.
Tsachouridou O; Skoura L; Chatzidimitriou D; Margariti A; Georgiou A; Chatzidimitriou M; Bougiouklis D; Zebekakis P; Metallidis S
Curr HIV Res; 2017; 15(4):285-290. PubMed ID: 28675993
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral therapy and intestinal microsporidiosis in Thai HIV infected patients.
Wiwanitkit V
Parasite; 2007 Sep; 14(3):252. PubMed ID: 17933304
[No Abstract] [Full Text] [Related]
8. Etiology of neutropenia in HIV-infected patients.
Jaresko GS
Am J Health Syst Pharm; 1999 Dec; 56 Suppl 5():S5-8. PubMed ID: 10613380
[TBL] [Abstract][Full Text] [Related]
9. Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy.
Willemot P; Klein MB
Expert Rev Anti Infect Ther; 2004 Aug; 2(4):521-32. PubMed ID: 15482218
[TBL] [Abstract][Full Text] [Related]
10. Complications of HIV disease and antiretroviral therapy.
Havlir DV; Currier JS
Top HIV Med; 2006; 14(1):27-35. PubMed ID: 16641525
[TBL] [Abstract][Full Text] [Related]
11. [Follow up of HIV-infected patients on antiretroviral treatment].
Chirouze C; Hoen B
Rev Prat; 2006 May; 56(9):966-75. PubMed ID: 16775977
[TBL] [Abstract][Full Text] [Related]
12. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
13. Infection prophylaxis and antiretroviral therapy in patients with HIV infection and malignancy.
Sparano JA; Sarta C
Curr Opin Oncol; 1996 Sep; 8(5):392-9. PubMed ID: 8914806
[TBL] [Abstract][Full Text] [Related]
14. Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy.
French MA
Curr HIV/AIDS Rep; 2007 Feb; 4(1):16-21. PubMed ID: 17338856
[TBL] [Abstract][Full Text] [Related]
15. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
16. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
17. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy.
Schmidt-Westhausen AM; Priepke F; Bergmann FJ; Reichart PA
J Oral Pathol Med; 2000 Aug; 29(7):336-41. PubMed ID: 10947250
[TBL] [Abstract][Full Text] [Related]
18. Prevention of opportunistic infections in the era of improved antiretroviral therapy.
Chaisson RE; Moore RD
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 16 Suppl 1():S14-22. PubMed ID: 9389311
[TBL] [Abstract][Full Text] [Related]
19. Treatment of HIV-related neutropenia.
Wong RJ
Am J Health Syst Pharm; 1999 Dec; 56 Suppl 5():S17-20. PubMed ID: 10613382
[TBL] [Abstract][Full Text] [Related]
20. Oral innate immunity in HIV infection in HAART era.
Nittayananta W; Tao R; Jiang L; Peng Y; Huang Y
J Oral Pathol Med; 2016 Jan; 45(1):3-8. PubMed ID: 25639844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
